The return on investment in health care: From 1980 to 2000

被引:53
作者
Luce, BR
Mauskopf, J
Sloan, FA
Ostermann, J
Paramore, LC
机构
[1] United BioSource Corp, Bethesda, MD 20814 USA
[2] RTI Int, Durham, NC USA
[3] Duke Univ, Durham, NC USA
关键词
health policy; innovation; Medicare claims; return on investment;
D O I
10.1111/j.1524-4733.2006.00095.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: To estimate the return on US investment (ROI) in overall health as well as four specific conditions. Methods: The study utilized three distinct approaches to "triangulate" the evidence as related to ROI in health care: 1) an estimation of the average ROI in additional health-care service expenditures in the United States for the year 2000 compared with the year 1980, based on US summaries of health expenditures and health outcomes; 2) an estimate of the ROI in Medicare services for the period from 1985 to 2000 for treatment of heart attack, stroke, type 2 diabetes, and breast cancer, based on National Long-term Care Survey data and Medicare claims; and 3) an estimate of the ROI for selected major treatment innovations for the same four conditions during the period from 1975 to 2000. Results: We calculated that each additional dollar spent on overall health-care services produced health gains valued at $1.55 to $1.94 under our base case assumptions. The return on health gains associated with treatment for heart attack, stroke, type 2 diabetes, and breast cancer were $1.10, $1.49, $1.55, and $4.80, respectively, for every additional dollar spent by Medicare. The ROI for specific treatment innovations ranged from both savings in treatment costs and gains in health to gains in health valued at $1.12 to $38.00 for every additional dollar spent. Conclusion: The value of improved health in the US population in 2000 compared with 1980 significantly outweighs the additional health-care expenditures in 2000 compared with 1980.
引用
收藏
页码:146 / 156
页数:11
相关论文
共 47 条
[1]  
*ASS PRESS, 2004, WASHINGTON POST 0907, pA8
[2]  
BLOMQUIST GC, 2001, EC VALUE LIFE INT EN
[3]  
Bureau of Labor Statistics of the US Department of Labor, CONS PRIC IND
[4]  
[Center for Disease Control U. S. Department of Health and Human Services Center for Disease Control], 2002, DHHS PUBL
[5]   Cost-effectiveness of coronary stenting in acute myocardial infarction - Results from the stent primary angioplasty in myocardial infarction (Stent-PAMI) trial [J].
Cohen, DJ ;
Taira, DA ;
Berezin, R ;
Cox, DA ;
Morice, MC ;
Stone, GW ;
Grines, CL .
CIRCULATION, 2001, 104 (25) :3039-3045
[6]  
CRETIN S, 1977, HEALTH SERV RES, V12, P174
[7]  
*CTR MED MED SERV, 2002, 2002 NAT HLTH CAR EX
[8]  
Cutler D, 2001, W8556 NAT BUR EC RES
[9]  
Cutler DM, 1999, EC BETTER HLTH CASE
[10]  
CUTLER DM, 1997, MEASURING HLTH US PO